Advertisement

Hypertension

  • Mark T. O’Connell

Abstract

Because of the large number of affected individuals and the well-established cardiovascular risks, high blood pressure is quantitatively the largest single risk for premature death and disability in the Western world. Although the working definition of hypertension varies from source to source, most surveys reveal that between 15 and 25% of adult, western populations have significantly elevated systemic arterial blood pressures.1 Effective treatment of hypertension has had a significant impact on its associated morbidity and mortality. In the 1960s less than one-half of individuals found to have high blood pressure had been previously diagnosed, and less than one-sixth were adequately treated. This situation improved significantly during the 1970s. Thanks to both government and private efforts to increase the public’s awareness, by the late 1970s approximately two-thirds of hypertensive patients had been diagnosed and nearly one-half were being adequately treated.

Keywords

Blood Pressure Diastolic Blood Pressure Hypertensive Patient High Blood Pressure Essential Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    National Center for Health Statistics: Monthly Vital Statistics Rep. 29: 1–9, 1981.Google Scholar
  2. 2.
    Rose, G.: Strategy of prevention: Lessons from cardiovascular disease. Br. Med. J. 282: 1847–1850, 1981.CrossRefGoogle Scholar
  3. 3.
    Kirkendall, W. M., Feinleib, M., Freis, E. D., et al.: Recommendations for Human Blood Pressure Determination by Sphygmomanometers. American Heart Association, New York, 1980.Google Scholar
  4. 4.
    Simpson, J. A., Jamieson, G., Dickhaus, D. W., et al.: Effect of size of cuff bladder on accuracy of measurement of indirect blood pressure. Am. Heart J. 70: 208–211, 1965.PubMedCrossRefGoogle Scholar
  5. 5.
    Karvonen, M. J., Telivuo, L. J., and Jarnieven, E. J. K.: Sphygmomanometer cuff size and the accuracy of indirect measurement of blood pressure. Am. J. Cardiol. 13: 688–691, 1964.PubMedCrossRefGoogle Scholar
  6. 6.
    King, G. E.: Taking the blood pressure. JAMA 209: 1902, 1969.PubMedCrossRefGoogle Scholar
  7. 7.
    Armitage, P., Fox, W., and Rose, G.: The variability of measurements of casual blood pressure. Clin. Sci. 30: 337–340, 1966.PubMedGoogle Scholar
  8. 8.
    Marshall, A. J., and Barrit, D. W. (eds.): The Hypertensive Patient. Pitman Medical Press, Kent, 1980.Google Scholar
  9. 9.
    Pickering, G.: Hypertension. Definitions, natural histories and consequences. Am. J. Med. 52: 570–577, 1972.PubMedCrossRefGoogle Scholar
  10. 10.
    The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med. 144: 1045–1057, 1984.CrossRefGoogle Scholar
  11. 11.
    Lerner, D. J., and Kannel, W. B.: Patterns of coronary heart disease morbidity and mortality in sexes: A 26-year follow-up of the Framingham population. Am. Heart J. 111: 383–387, 1986.PubMedCrossRefGoogle Scholar
  12. 12.
    Neaton, J. D., Kuller, L. H., Wentwork, D., et al.: Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am. Heart J. 108: 759–766, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Franco, L. J., Stern, M. P., Rosenthal, M., et al.: Coffee consumption, diet, and lipids. Am. J. Epidemiol. 121: 684–687, 1985.PubMedCrossRefGoogle Scholar
  14. 14.
    DeStefano, F., Coulehan, J. L., and Wlant, M. K.: Prevalence, detection, and control of hypertension in a biethnic community. Am. J. Epidemiol. 109: 335–340, 1979.PubMedGoogle Scholar
  15. 15.
    Stamler, R., Stamler, J., Reidlinger, W. F., et al.: Family (parental) history and prevalence of hypertension. JAMA 241: 43–48, 1979.PubMedCrossRefGoogle Scholar
  16. 16.
    Dustan, H. P.: in Lauer, R. M., and Shehelle, R. B. (eds.): Childhood Prevention of Atherosclerosis and Hypertension. Raven Press, New York, 1980.Google Scholar
  17. 17.
    Havlik, R. J., Hubert, H. B., Fabsitz, R. R., et al.: Weight and hypertension. Ann. Intern. Med. 98: 855–859, 1983.PubMedGoogle Scholar
  18. 18.
    Paul, O. (ed.): Epidemiology and Control of Hypertension. Stratton Intercontinental, New York, 1975.Google Scholar
  19. 19.
    Cobb, S., and Rose, R. M.: Hypertension, peptic ulcer, and diabetes in air traffic controllers. JAMA 224: 489–493, 1973.PubMedCrossRefGoogle Scholar
  20. 20.
    Sever, P.S., Gordon, D., Peart, W. S., et al.: Blood pressure and its correlates in urban and tribal Africa. Lancet 2: 60–61, 1980.PubMedCrossRefGoogle Scholar
  21. 21.
    Monk, M.: Psychologic status and hypertension. Am. J. Epidemiol. 112: 200–203, 1980.PubMedGoogle Scholar
  22. 22.
    Dworkin, B. R., Filearich, R. J., Miller, N. E., et al.: Baroreceptor activation reduces reactivity to noxious stimulation: Implications for hypertension. Science 205: 1299–1300, 1979.PubMedCrossRefGoogle Scholar
  23. 23.
    Freis, E. D.: Salt, volume and the prevention of hypertension. Circulation 53: 589–593, 1976.PubMedGoogle Scholar
  24. 24.
    Garcia-Palmieri, M. R., Costas, R., Cruz-Vidal, M., et al.: Milk consumption, calcium intake, and decreased hypertension. Hypertension 6: 322–326, 1984.PubMedGoogle Scholar
  25. 25.
    Tobain, L.: The relationship of salt to hypertension. Am. J. Clin. Nutr. 32: 2739–2741, 1979.Google Scholar
  26. 26.
    Robertson, E., Wade, D., Workman, R., et al.: Tolerance to the humoral and hemodynamic effects of caffeine in man. J. Clin. Invest. 67: 1111–1113, 1981.PubMedCrossRefGoogle Scholar
  27. 27.
    Doll, R., and Peto, R.: Mortality in relation to smoking: 20 years observations on male British doctors. Br. Med. J. 2: 1525–1528, 1976.PubMedCrossRefGoogle Scholar
  28. 28.
    Harburg, E., Ozgoren, F., Hawthorne, V. W., et al.: Community norms of alcohol usage and blood pressure: Tecumseh, Michigan. Am. J. Public Health 70: 813–816, 1980.PubMedCrossRefGoogle Scholar
  29. 29.
    Castelli, W. P.: Epidemiology of coronary heart disease: The Framingham Study. Am. J. Med. 76(2A): 4–8, 1984.PubMedCrossRefGoogle Scholar
  30. 30.
    The Pooling Project Research Group: Final report of the Pooling Project. J. Chronic Dis. 31(4): 201–206, 1978.CrossRefGoogle Scholar
  31. 31.
    VA Co-op: Effects of treatment on morbidity in hypertension. Results in patients diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202: 1028–1031, 1967.CrossRefGoogle Scholar
  32. 32.
    VA Co-op: Effects of treatment on morbidity in hypertension. Results in patients diastolic blood pressure averaging 90 through 11 mm Hg. JAMA 213: 1143–1146, 1970.CrossRefGoogle Scholar
  33. 33.
    Smith, W. M.: Treatment of mild hypertension: Results of a ten-year intervention trial. Circ. Res. 40 (suppl 1): 98–101, 1977.Google Scholar
  34. 34.
    Hypertension Detection and Follow-up Program Cooperative Group: Five year findings of hypertension detection and follow-up program. II. Reduction in stroke incidence among persons with high blood pressure. JAMA 247: 633–635, 1982.CrossRefGoogle Scholar
  35. 35.
    Helgeland, A.: Treatment of mild hypertension: A five year controlled drug trial. Am. J. Med. 69: 725–727, 1980.PubMedCrossRefGoogle Scholar
  36. 36.
    Management Committee: The Australian therapeutic trial in mild hypertension. Lancet 1: 1261–1263, 1980.Google Scholar
  37. 37.
    Multiple Risk Factor Intervention Trial Research Group: Risk factor changes and mortality results. JAMA 248: 1465–1472, 1982.CrossRefGoogle Scholar
  38. 38.
    Medical Research Council Working Party: MRC trial of treatment of mild hypertension: Principal results. Br. Med. J. 291: 97–99, 1985.CrossRefGoogle Scholar
  39. 39.
    Nordrehaug, J. E., Johannesseen, K. A., and von-der-Lippe, G.: Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation 71: 645–648, 1985.PubMedCrossRefGoogle Scholar
  40. 40.
    Dyckner, T., Helmers, C., and Webster, P. O.: Cardiac dysrhythmias in patients with acute myocardial infarction. Relation to serum potassium level and prior diuretic therapy. Acta Med. Scand. 216: 127–142, 1984.PubMedCrossRefGoogle Scholar
  41. 41.
    Oliver, W. J., Cohen, E. L., Neel, J. V., et al.: Blood pressure sodium intake and sodium related hormones in the Yanomamo Indians, a “no salt” culture. Circulation 52: 146–151, 1975.PubMedGoogle Scholar
  42. 42.
    Lowenstein, F. W.: Blood pressure in relation to age and sex in the tropics and subtropic. A review of the literature and an investigation in two tribes of Brazil Indians. Lancet 1: 389–390, 1961.CrossRefGoogle Scholar
  43. 43.
    Prior, A. M., Evans, J. G., Harvey, H. P. B., et al.: Sodium intake and blood pressure in two Polynesian populations. N. Engl. J. Med. 279: 515–518, 1968.PubMedCrossRefGoogle Scholar
  44. 44.
    Sinnet, P. F., and Whyte, H. M.: Epidemiologic studies in the total highland population, Tukisenta, New Guinea. J. Chronic Dis. 26: 265–269, 1973.CrossRefGoogle Scholar
  45. 45.
    Maddocks, I.: Blood pressure in Melanesians. Med. J. Aust. 1: 1123–1124, 1967.PubMedGoogle Scholar
  46. 46.
    Dahl, L. K.: Salt and hypertension. Am. J. Clin. Nutr. 25: 231–238, 1972.PubMedGoogle Scholar
  47. 47.
    Genest, J., Koiw, E., and Kuchel, O. (eds.): Hypertension: Physiopathology and Treatment. McGraw-Hill, New York, 1977.Google Scholar
  48. 48.
    Hypertension Detection and Follow-up Program. Circ. Res. 40(suppl): 106, 1977.Google Scholar
  49. 49.
    Sever, P.S., Gordon, D., Peart, W. S., et al.: Blood pressure and its correlates in urban and tribal Africa. Lancet 2: 60–62, 1980.PubMedCrossRefGoogle Scholar
  50. 50.
    Kempner, W.: Am. J. Med. 4: 545–548, 1948.PubMedCrossRefGoogle Scholar
  51. 51.
    Parijs, J., Joossens, J. V., Van der Linden, L., et al.: Moderate sodium restriction and diuretics in the treatment of hypertension. Am. Heart J. 85: 22–34, 1973.PubMedCrossRefGoogle Scholar
  52. 52.
    Morgan, T., Gillies, A., Morgan, G., et al.: Hypertension treated by salt restriction. Lancet 1: 227–230, 1978.PubMedCrossRefGoogle Scholar
  53. 53.
    MacGregor, G. A., Markandu, N. D., Best, F. E., et al.: Double-blind randomized crossover tiral of moderate sodium restriction in essential hypertension. Lancet 1: 235–351, 1982.Google Scholar
  54. 54.
    Watt, G. C. M., Edwards, C., Hart, J., et al.: Dietary restriction for mild hypertensives in general practice. Br. Med. J. 286: 432–436, 1983.CrossRefGoogle Scholar
  55. 55.
    Morgan, T. O., and Myers, J. B., Hypertension treated by sodium restriction. Med. J. Aust. 2: 396–397, 1981.PubMedGoogle Scholar
  56. 56.
    Kannel, W. B., Brund, N., Skinner, J. J., et al.: The relation of adiposity to blood pressure and development of hypertension. Ann. Intern. Med. 67: 48–52, 1967.PubMedGoogle Scholar
  57. 57.
    Reisen, E., Abel, R., et al.: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N. Engl. J. Med. 298: 1–6, 1978.CrossRefGoogle Scholar
  58. 58.
    Tuck, M. L., Sowers, J., Modan, M., et al.: The effect of weight reduction on blood pressure plasma renin activity, and plasma aldosterone levels in obese patients. N. Engl. J. Med. 304: 930–933, 1981.PubMedCrossRefGoogle Scholar
  59. 59.
    Reisen, E., Frohlich, E. D., Dornfeld, L., et al.: Cardiovascular changes after weight reduction in obesity hypertension. Ann. Intern. Med. 98: 315–319, 1983.Google Scholar
  60. 60.
    Maxwell, M. H., Kushiro, T., Dornfeld, L. P., Messerli, F. H., et al.: Blood pressure changes in obese hypertensive subjects during rapid weight loss. Comparison on restricted vs unchanged salt intake. Arch. Intern. Med. 144: 1581–1584, 1984.PubMedCrossRefGoogle Scholar
  61. 61.
    McMahon, F. G.: Management of Essential Hypertension; the New Low Dose Era. Futura, New York, 1984, p. 46.Google Scholar
  62. 62.
    Choquette, G., and Ferguson, R. J.: Blood pressure reduction in “borderline” hypertensives following physical training. Can. Med. Assoc. J. 108: 699–702, 1973.PubMedGoogle Scholar
  63. 63.
    Cade, R., Mars, D., Wagemaker, H., et al.: Effect of aerobic exercise training on patients with systemic arterial hypertension. Am. J. Med. 77: 785–789, 1984.PubMedCrossRefGoogle Scholar
  64. 64.
    Boyer, J. L., and Kasch, F. W.: Exercise therapy in hypertensive men. JAMA 211: 1668–1671, 1970.PubMedCrossRefGoogle Scholar
  65. 65.
    Bonanno, J. A., and Lies, J. E.: Effects of physical training on coronary risk factors. Am. J. Cardiol. 33: 760–764, 1974.PubMedCrossRefGoogle Scholar
  66. 66.
    Roman, O., Camuzzi, A., Villalon, E., et al.: Physical training program in arterial hypertension: A long-term prospective follow-up. Cardiology 67: 230–243, 1981.PubMedCrossRefGoogle Scholar
  67. 67.
    Krotkiewski, M., Mandroukas, K., Sjostrom, L., et al.: Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism 28: 650–658, 1979.PubMedCrossRefGoogle Scholar
  68. 68.
    Jacobson, E.: Variation of blood pressure with skeletal muscle tension and relaxation. Ann. Intern. Med. 12: 1194–1212, 1939.Google Scholar
  69. 69.
    Black, H. R.: Nonpharmacologic therapy for hypertension. Am. J. Med. 66: 837–842, 1979.PubMedCrossRefGoogle Scholar
  70. 70.
    Agras, W. S.: Behavioral approaches to the treatment of essential hypertension. Int. J. Obesity 5: 100–106, 1981.Google Scholar
  71. 71.
    Ophir, O., Peer, G., Gilad, J., et al.: Low blood pressure in vegetarians: The possible role of potassium. Am. J. Clin. Nutr. 37: 755–759, 1983.PubMedGoogle Scholar
  72. 72.
    Puska, P., Iacono, J. M., et al.: Controlled, randomized trial of the effect of dietary fat on blood pressure. Lancet 1: 1–5, 1983.PubMedCrossRefGoogle Scholar
  73. 73.
    Rouse, I. L., Beilin, L. J., Armstrong, B. K., et al.: Blood pressure-lowering effect of a vegetarian diet: Controlled trial in normotensive subjects. Lancet 1: 5–10, 1983.PubMedCrossRefGoogle Scholar
  74. 74.
    Iacono, J. M., and Marshall, M. W.: Reduction in blood pressure associated with high polyunsaturated fat diets that reduce blood cholesterol in man. Prev. Med. 4: 426–443, 1975.PubMedCrossRefGoogle Scholar
  75. 75.
    Rao, R. H., Rao, U. B., and Srikantia, S. G.: Effect of polyunsaturated-rich vegetable oils on blood pressure in essential hypertension. Clin. Exp. Hypertension 3(1): 27–38, 1981.CrossRefGoogle Scholar
  76. 76.
    Addison, W. T. L.: The use of sodium chloride, potassium chloride, sodium bromide, and potassium bromide in cases of arterial hypertension. Can. Med. Assoc. J. 18: 281–288, 1928.PubMedGoogle Scholar
  77. 77.
    Reed, D., McGee, Yano, K., et al.: Diet, blood pressure, and multicollinearity. Hypertension 7: 405, 1985.PubMedGoogle Scholar
  78. 78.
    Staessen, J., Bulpitt, C., Fagard, R., et al.: Four urinary cations and blood pressure-a population study of two Belgian towns. International Symposium on Potassium, Blood Pressure and Cardiovascular Disease. Excerpta Medica, Amsterdam, 1983.Google Scholar
  79. 79.
    Khaw, K. T., and Rose, G.: Population study of blood pressure and associated factors in St. Lucia, West Indies. Int. J. Epidemiol. 11: 372–377, 1982.PubMedCrossRefGoogle Scholar
  80. 80.
    Walker, W. C., Whelton, P. K., Saito, H., et al.: Relation between blood pressure and renin, renin substrate, angiotension II, aldosterone, and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1(3): 287–291, 1979.PubMedGoogle Scholar
  81. 81.
    Ericsson, F., Clarkmark, B., Elliasson, K., et al.: potassium in whole body and skeletal muscle in untreated primary hypertension. International Symposium on Potassium, Blood Pressure and Cardiovascular disease. Excerpta Medica, Amsterdam, 1983.Google Scholar
  82. 82.
    Parfrey, P. S., Vandenburg, M. J., Wright, P., et al.: Blood pressure and hormonal changes following alteration in dietary sodium and potassium in mild essential hypertension. Lancet 1: 59–63, 1981.PubMedCrossRefGoogle Scholar
  83. 83.
    MacGregor, G. A., Smith, S. J., Markandu, N. D., et al.: Moderate potassium supplementation in essential hypertension. Lancet 2: 567–570, 1982.PubMedCrossRefGoogle Scholar
  84. 84.
    Khaw, K. T., and Thorn, S.: Randomized double-blind crossover trial of potassium on blood pressure in normal subjects. Lancet 2: 1127–1129, 1982.PubMedCrossRefGoogle Scholar
  85. 85.
    Iimura, O., Kyima, T., Kikuchi, K., et al.: Studies on the hypotensive effect of high potassium intake in patients with essential hypertension. Clin. Sci. 61: 77–90, 1981.Google Scholar
  86. 86.
    Mazzola, C., and Guffanti, E.: Cardiovascular modifications after K+ supplementation in hypertensive patients. International Symposium on Potassium, Blood Pressure, and Cardiovascular Disease. Excerpta Medica, Amsterdam, 1983.Google Scholar
  87. 87.
    Kaplan, N. M., Carnegie, A., Raskin, P., et al.: Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N. Engl. J. Med. 312: 746–749, 1985.PubMedCrossRefGoogle Scholar
  88. 88.
    Skrabal, F., Auboch, J., and Hortnagl, H.: Low sodium/high potassium diet for prevention of hypertension: Probable mechanisms of action. Lancet 2: 895–900, 1981.PubMedCrossRefGoogle Scholar
  89. 89.
    Shaper, A. G.: Soft water, heart attacks, and stroke. JAMA 230: 130–134, 1974.PubMedCrossRefGoogle Scholar
  90. 90.
    McCarron, D. A., Morris, C. D., and Cole, C.: Dietary calcium in human hypertension. Science 217: 267–269, 1982.PubMedCrossRefGoogle Scholar
  91. 91.
    McCarron, D. A.: Low serum concentrations of ionized calcium in patients with hypertension. N. Engl. J. Med. 307: 226–228, 1982.PubMedCrossRefGoogle Scholar
  92. 92.
    Belzian, J. M., Villar, J., Pineda, O., et al.: Reduction of blood pressure with calcium supplementation in young adults. JAMA 249: 1161–1165, 1983.CrossRefGoogle Scholar
  93. 93.
    McCarron, D. A., and Morris, C. D.: Blood pressure response to oral calcium in persons with mild to moderate hypertension. A randomized, double-blind, placebo-controlled, crossover trial. Ann. Intern. Med. 103: 825–829, 1985.PubMedGoogle Scholar
  94. 94.
    Lewin, A., Blaufox, D., Castle, H., et al.: Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. Arch. Intern. Med. 145: 424–429, 1985.PubMedCrossRefGoogle Scholar
  95. 95.
    Kaplan, N. M. (ed.): Clinical Hypertension, 4th ed. Williams & Wilkins, Baltimore, 1986.Google Scholar
  96. 96.
    Svardsudd, K., Wedel, H., Aurell, E., et al.: Hypertensive eye ground changes. Prevalence, relation to blood pressure and prognostic importance. The study of men born in 1913. Acta Med. Scand. 204: 159–163, 1978.PubMedCrossRefGoogle Scholar
  97. 97.
    Schatzkin, A., Cupples, L. A., Heeren, T., et al.: The epidemiology of sudden unexpected death: Risk factors for men and women in the Framingham Heart Study. Am. Heart J. 107: 1300–1308, 1984.PubMedCrossRefGoogle Scholar
  98. 98.
    Coronary Risk Handbook. American Heart Association, New York, 1973.Google Scholar
  99. 99.
    Feinleib. M.: The magnitude and the nature of the decrease in coronary heart disease mortality rate. Am. J. Cordial. 54 (suppl): 2c–10c, 1984.CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Mark T. O’Connell
    • 1
  1. 1.Department of MedicineUniversity of Miami School of MedicineMiamiUSA

Personalised recommendations